![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 20, 14846-14852, May 19, 2000
§,
§,
,
,
From the
Posttranscriptional Control Group,
Department of Biomolecular Sciences, University of Manchester
Institute of Science and Technology, Manchester M60 1QD, United Kingdom
and ¶ Department of Biochemistry, Technische Universität
Braunschweig, Mascheroder Weg 1, D-38124 Braunschweig, Germany
| |
ABSTRACT |
|---|
|
|
|---|
The synthesis of eukaryotic selenoproteins
involves the recoding of an internal UGA codon as a site for
selenocysteine incorporation. This recoding event is directed by a
selenocysteine insertion sequence in the 3'-untranslated region.
Because UGA also functions as a signal for peptidyl-tRNA hydrolysis, we
have investigated how the rates of translational termination and
selenocysteine incorporation relate to cis-acting elements
in the mRNA as well as to trans-acting factors in the
cytoplasm. We used cis-elements from the phospholipid
glutathione peroxidase gene as the basis for this work because of its
relatively high efficiency of selenocysteine incorporation. The last
two codons preceding the UGA were found to exert a far greater
influence on selenocysteine incorporation than nucleotides downstream
of it. The efficiency of selenocysteine incorporation was generally
much less than 100% but could be partially enhanced by concomitant
overexpression of the tRNASec gene. The combination of two
or three UGA codons in one reading frame led to a dramatic reduction in
the yield of full-length protein. It is therefore unlikely that
multiple incorporations of selenocysteine are processive with respect
to the mode of action of the ribosomal complex binding to the UGA site.
These observations are discussed in terms of the mechanism of
selenoprotein synthesis and its ability to compete with termination at
UGA codons.
Selenocysteine, the twenty-first amino acid (1, 2), is
cotranslationally incorporated into a number of prokaryotic and eukaryotic proteins (3, 4). Although many of the basic mechanistic principles underlying this process in bacteria have been elucidated, the incorporation pathway in eukaryotic cells remains unknown. In all
systems studied so far, the opal nonsense codon UGA is given an
alternative coding status that allows it to encode selenocysteine. In
Escherichia coli, this recoding depends on the presence of a
stem-loop structure bearing specific sequences immediately 3' of the
UGA (5). Unlike its prokaryotic counterpart, the eukaryotic element is
located in the 3'-untranslated region (3'-UTR; Ref. 6),1 and is capable of acting
at distances greater than 5000 nucleotides (7, 8). This element has
been called the selenocysteine insertion sequence (SECIS). The highly
conserved sequences in the SECIS element are: AAA in or near the apical
loop, GA on the 3' side of the stem, and AUGA on the 5' side of the
stem. A particular focus of attention has recently been the sequence
region including the GA and AUGA elements, which is thought to form a
non-Watson-Crick base paired duplex structure (9, 10).
The recoding of UGA depends on a number of specific
trans-acting components. In bacteria, a special type of
seryl-tRNA (tRNASec; SelC) decodes the opal codon as
selenocysteine with the assistance of a dedicated EF-Tu-like factor
called SelB (1, 2, 11, 12). The synthesis of
selenocysteyl-tRNASec from seryl-tRNASec
requires three further proteins (SelA, SelC, and SelD; Refs. 13-15).
The greatest stumbling block to elucidating the mechanism of
selenocysteine incorporation in eukaryotes has been uncertainty as to
the nature of the eukaryotic equivalent(s) to SelB. There have been
reports of at least four different SECIS-binding proteins (16-20). So
far, a 120-kDa protein seems to be the most likely candidate for
binding specifically to SECIS elements (20), but further work will be
needed to determine the other binding partners of this factor and its
role in the selenocysteine incorporation process. Most importantly,
there is evidence that the 120-kDa protein forms a complex with other
proteins, which may mean that the identified SECIS-binding factor is
only part of a multicomponent machinery. One potential component of
such a complex could be the
selenocysteyl-tRNASec-protecting factor described by Yamada
and colleagues (21).
An important unresolved question is to what extent the synthesis of
polypeptide chains beyond an internal UGA codon by virtue of
selenocysteine incorporation may be substoichiometric. This would
explain why the substitution of a cysteine codon (UGU or UGC) at the
site of a UGA results in greatly enhanced levels of polypeptide
synthesis (22-24). At the same time, it is essential to consider the
implications of UGA recoding for the termination process on the
ribosome. It has been suggested that unless the distance between the
UGA and the SECIS element is suboptimal, termination will be suppressed
(3). However, there has been no systematic study to date of the
relationship between translation termination and selenocysteine
incorporation. In the present work we examine the properties of the UGA
site that can influence both the efficiency with which selenocysteine
is incorporated and the rate of polypeptide chain termination. There is
a further aspect of selenoprotein synthesis that has previously
remained unexplained. Genes such as those encoding selenoprotein P (25)
and human type 2 iodothyronine deiodinase (8) contain multiple UGA
codons. This raises the question as to how selenocysteine can be
repeatedly inserted at up to 10 positions within the same polypeptide.
In the following work, we examine whether processivity is likely to be
the molecular basis for this phenomenon.
Plasmid Constructs--
All DNA manipulations were performed
according to standard protocols (26). Synthetic oligonucleotides used
in plasmid constructions are listed in Table
I. To construct the master plasmids pH8A and pH9A, the oligonucleotide pair (PHGPXL-A and PHGPXSL-B) containing the in-frame TGA codon of the phospholipid hydroperoxide glutathione peroxidase gene (nucleotides 165-255) of S. scrofa
(GenBankTM accession number X76009) was subcloned between
the BamHI and SalI sites of the plasmids pBLUGA
and pBPHGPx3U (23). PBPHGPx3U contains the PHGPx SECIS element in its
3'-UTR. To mutate the TGA codon to TGC, PCR was carried out using the
primers PHGP-Xho and PHGP-Bam, and the resulting PCR fragment was
inserted between the SalI and BamHI sites of the
plasmids pBLUGA and pBPHGPx3U. The resulting plasmids were designated
pH8B and pH9B. To mutate the fourth base G to A, C, and T, several PCRs
were carried out using the forward primers PHGP-A, PHGP-C, and PHGP-T
combined with PHGP-Bam as a reverse primer, respectively. The resulting PCR fragments were inserted between the SalI and
BamHI sites of the plasmids pBPLUGA and pBPHGPx3U. The
resulting plasmids were designated pT11-pT16. The nature of the fourth
base and the presence or absence of the PHGPx SECIS element are
indicated in Table II.
To mutate the penultimate codons positioned at
To investigate selenocysteine incorporation at multiple sites,
additional in-frame TGA codons were inserted in the
lacZ::luc reporter system. The oligonucleotide
pairs SelP1X-A/B, SelP2X-A/B, SelP12X-A/B, and SelP12C-A/B containing
the selenoprotein P gene of H. sapiens
(GenBankTM accession number Z11793, amino acids 300-318;
the in-frame TGA codons are located at positions 300 and 318) were
subcloned in the BamHI site of the plasmids pH8A, pH8B,
pH9A, and pH9B. The oligonucleotide pairs contain TGA and TGC codons in
various combinations so that the constructs contain one, two, or three TGA (or TGC) codons. The resulting plasmids were designated pT18-pT33. The plasmids are listed in Table II.
Xenopus tRNASec (the SelC equivalent) and the SelD gene
(SelD4-CDM8) were provided by Dr. Alain Krol (27) and Dr. Marla Berry (28), respectively. The Xenopus release factor genes were
supplied already cloned in the expression plasmids pCYM1-11/XSUP35
(29) and pXLCL1 (30) by Prof. Michel Philippe (CNRS, Rennes, France).
Cell Culture, Gene Transfer, and Enzyme Assays--
BHK-21 cells
(baby hamster kidney cells; ATCC CC110) were cultivated as described
elsewhere (24). Transient transfections were performed using Superfect
transfection reagent (Qiagen) following the manufacturer's protocol.
RNA Isolation and Reverse Transcriptase-PCR--
Isolation of
total RNA and reverse transcriptase-PCR were performed using TRIzol®
reagent and SuperscriptTM (Life Technologies),
respectively, following the manufacturer's protocols. PCR was
performed using primers against the lacZ::luc mRNA and against actin mRNA (as a reference) for 22, 26, 32, and 36 cycles.
SDS-Polyacrylamide Gel Electrophoresis and Western
Blotting--
SDS-polyacrylamide gel electrophoresis was carried out
according to the protocol described by Laemmli (31). Western blotting was performed using a semi-dry method (32) using cell extracts prepared
according to an earlier protocoll (24).
Determination of Selenocysteine Incorporation and Translation
Termination--
The reporter system used in this work is based on the
genes encoding The Environment of the UGA--
The first stage of our
investigation of the factors influencing selenocysteine incorporation
efficiency in mammalian selenoproteins focused on the role of the
immediate environment of the UGA site. It was our intention to obtain
information about the possible upper limits of incorporation
efficiency. We therefore chose the pig heart phospholipid hydroperoxide
glutathione peroxidase (PHGPx; Ref. 33) gene as a starting point,
because previous work had shown that the SECIS of this gene supported a
higher incorporation efficiency than the other SECIS elements tested
(24). We used a fusion reporter system (Ref. 24 and Fig.
1) to study the influence of the UGA
environment. In using this system, we compare the suppression of
termination at the central UGA in the presence and in the absence of
the SECIS element. In this way, we can determine the recoding that is
strictly related to a SECIS-dependent pathway, which
reflects selenocysteine incorporation. The reporter gene system is
expressed from the SV40 promoter in vivo after transfection
of mammalian cells. Translation can either terminate at the C terminus
of lacZ or, upon suppression of the nonsense function of the
UGA codon, continue through the linker sequence to generate a fusion
protein of
We examined whether the activity of the PHGPx UGA, like its counterpart
in the type 1 deiodinase gene (34), is sensitive to the downstream
context. The results confirmed that SECIS-dependent incorporation is increased when the fourth base is a pyrimidine (Fig.
2B). This effect is therefore
common to different UGA contexts and SECIS elements. We wished to
compare this result with the effects of changes in other features of
the UGA context that have not previously been investigated. The first
of these is the potential influence of mRNA structure downstream of
the UGA. For example, a predicted stem-loop structure could potentially
be formed 9 nucleotides downstream of the UGA in the PHGPx gene (Fig.
2C). It is known that downstream structure plays a key role
in the selenocysteine incorporation process in E. coli (5).
Could it also at least modulate the efficiency of eukaryotic
selenocysteine incorporation, perhaps by virtue of its ability to cause
ribosomes to pause longer at the UGA? We investigated whether mutating
the putative stem-loop to destabilize it would affect selenocysteine incorporation (Fig. 2C). Any effect is evidently marginal,
thus indicating that downstream secondary structure is unlikely to be
involved in eukaryotic selenocysteine incorporation. We conclude that
the nature of the nucleotide at the +4 position relative to the UGA is
likely to be the most relevant feature of the downstream region in
terms of determination of the rate of selenocysteine incorporation.
In stark contrast to this latter result, we found that changes in the
codons immediately upstream of the UGA can markedly affect
selenocysteine incorporation efficiency (Fig.
3). We replaced the penultimate and final
amino acid encoding triplets preceding the UGA in PHGPx with two codons
that belong to a group of termination-promoting codons (Fig.
3A and Ref. 35). The impact on selenocysteine incorporation was dramatic. We also observed that the combination of amino acids substituted in these experiments is avoided in all of the known UGA
gene contexts found in selenoprotein genes (Fig. 3B). We
conclude from this result that the selenocysteine incorporation rate of the PHGPx UGA is not normally restricted by the presence of 5' neighbor
codons that promote strong termination. Indeed, overall we were not
able to identify any cis-acting elements within the open
reading frame that could markedly improve selenocysteine incorporation
efficiency at the PHGPx UGA.
Modulation by Trans-acting Factors--
We investigated whether
the use of a reporter system introduced by transient transfection might
lead to partial saturation of the selenocysteine incorporation
machinery, thus potentially restricting the maximum attainable
efficiency of selenocysteine incorporation. The results of earlier
studies were not conclusive. One group found that co-transfection of
tRNASec (SelC) enhances selenocysteine incorporation in
transiently transfected human embryonic kidney cells (23), whereas
another group observed no increase in the synthesis of selenoproteins
as a consequence of tRNASec overexpression in Chinese
hamster ovary cells (36). To address this question in our reporter
system, we examined whether the co-transfection of a SelC expression
construct would affect the incorporation efficiencies. We found that
the incorporation efficiency at UGAG or UGAC was increased by up to
approximately 2-fold (Fig. 4). In further
experiments, we co-transfected both SelC and SelD. The addition of the
latter gene did not enhance the incorporation efficiency any further.
In fact, the co-transfection of both SelC and SelD yielded a somewhat
smaller enhancement in the incorporation efficiency. Overall,
therefore, some increase in selenocysteine incorporation efficiency was
supported by an enlargement in the size of the cellular
tRNASec pool.
There is some ambiguity about the dual role of internal UGA codons in
selenoprotein genes, in that estimates of the efficiency of
selenocysteine incorporation have varied from a few percent of the
polypeptide chains reaching the UGA being extended (23) to the
suggestion that this process fully suppresses termination (3).
Generally, the absolute efficiencies of selenocysteine incorporation in
the known selenoproteins remain unknown quantities. Clearly, if
termination and selenocysteine incorporation can both take place at the
same UGA, these two processes may effectively proceed competitively.
One possible way of testing this model is to examine whether increasing
the levels of the translation release factors leads to suppression of
selenocysteine incorporation. To perform this experiment, we
co-transfected individual reporter constructs together with expression
constructs bearing the genes encoding eRF1 and eRF3 (29, 30).
Comparison with the control construct pBLUGA revealed that there was
little specific repression of selenocysteine incorporation associated
with the overproduction of the eRFs (Fig. 4C).
Permutations of Multiple UGA Codons--
Further insight into the
mechanism of selenocysteine incorporation can be obtained by studying
how the system deals with open reading frames containing more than one
UGA. Three sites were used for the insertion of either UGA or UGC
(encoding cysteine; Fig. 5A).
One of these was the original PHGPx site used in the earlier
experiments (Fig. 2A), although the other two were excised from the SelP gene (nucleotides 934-990) and fused on to the 3' end of
the PHGPx gene segment. It was observed that the incorporation level
differed for the respective sites used in this experiment (I00, 0I0,
and 00I, Fig. 5B). The results described earlier in this
paper indicate that this variation can be explained at least partially
in terms of differences in the environment of each UGA. For example,
the distinct identities of the final codon pairs immediately 5' of each
UGA may contribute to the differences in incorporation efficiency. This
phenomenon was not investigated further because it is not of
immediate relevance to the main objective of the multiple UGA
experiments.
More strikingly, combining the individual UGAs in different
permutations in a single reading frame resulted in very marked reductions in SECIS-dependent suppression of
termination (Fig. 5B). The combination of UGAs at all
three sites resulted in particularly low yields of luciferase activity.
This effect was also evident in the amounts of
One potential role of SECIS elements, at least theoretically, could be
to suppress translation termination directly. However, the Western
blotting data (for example see Fig. 5C) clearly showed that
the yield of fusion protein was greatly reduced when multiple UGAs were
present in the reporter mRNA. Given that expression through the
lacZ domain was maintained (see above), this indicates that
the primary non-SECIS-dependent event at the UGA codons was termination, as opposed to amino acid misincorporation.
We have investigated a range of parameters that could influence
the efficiency of selenocysteine incorporation at single or multiple
sites in selenoprotein genes. A number of factors are capable of
attenuating the incorporation rate, but not sufficiently to suggest
that the normal cellular level of selenocysteine incorporation is
equivalent to 100% efficiency. Indeed, the data reported here, combined with the fact that there is considerable variation in the
efficiencies supported by different SECIS elements (3, 24), indicate
that termination occurs in parallel with selenocysteine incorporation
at the UGA sites in selenoprotein mRNAs. There may be considerable
variation in the relative rates of termination and selenocysteine
incorporation at different UGA codons. It is striking that using the
natural sequence contexts from selenoprotein genes in the expression
constructs described here, we have obtained higher absolute levels of
selenocysteine incorporation compared with the results obtained
previously using short, self-designed UGA-containing sequences (24).
However, the incorporation efficiencies obtained with transfected cells
may not be representative of the maximum attainable values. Indeed, the
incorporation efficiencies for natural genomic selenoprotein genes may
be higher.
An alternative model for the mode of action of the SECIS element is
that it not only promotes selenocysteine incorporation but also
directly suppresses translation termination at UGA codons. However,
unless there was a large increase in the mistranslation rate at the UGA
site, any suppression on termination rate would have to feed back on
the overall rate of protein synthesis. Because neither of these
phenomena were observed (Fig. 5), we conclude that this model does not
provide an adequate explanation of the results.
The competitive relationship between termination and selenocysteine
incorporation can be modulated by a number of manipulations in the
sequence region containing the UGA. Most strikingly, changes in the
penultimate codons that precede the UGA can have a dramatic effect on
the ability of the system to incorporate selenocysteine. However, we
have found that termination-promoting codons, and thus the encoded
amino acids, are evidently avoided among selenoprotein genes. The other
cis-acting elements in the neighborhood of the UGA, the
fourth nucleotide and downstream sequence and/or structure, exert a
comparatively minor influence on selenocysteine incorporation. The
observation that increased levels of eRFs have only a minimal observable effect on selenocysteine incorporation is not necessarily inconsistent with the existence of a competitive relationship with
termination, because these factors may be close to effective saturation
with respect to UGA-directed termination.
The consequences of the competition between termination and
selenocysteine incorporation in terms of mRNA stability are
difficult to predict. In principle, premature translational termination on an aberrant eukaryotic mRNA can trigger the so-called
nonsense-dependent mRNA decay pathway (37). However,
selenoprotein mRNAs may constitute a special case, given that the
internal stop codon fulfils a key function in the nonaberrant mRNA.
So far, it has been found that the stability of glutathione peroxidase
1 mRNA decreases significantly under conditions of selenium
limitation, whereas the destabilizing effect of ongoing termination
under nonselenium-limited conditions seems to be small (38, 39). In
contrast, even under selenium depletion conditions, neither PHGPx
mRNA nor gastrointestinal glutathione peroxidase mRNA is
destabilized by UGA-directed termination (38, 40). Our finding that the
stability of the reporter mRNA used in this work is not markedly
affected by changes in the efficiency or position of
UGA-dependent termination is therefore consistent with the
currently available data about the decay behavior of selenoprotein mRNAs.
We have established that termination and selenocysteine incorporation
can occur at varying ratios at the same UGA. How does this affect the
course of translation on selenoprotein mRNAs that have multiple
internal UGAs? If substoichiometric incorporation occurs at a series of
UGAs, the cumulative terminations at the successive sites would result
in a significantly reduced yield of full-length selenoprotein. If the
incorporation events are entirely independent, this yield would be
equivalent to the multiplicative sum of the efficiencies at the
individual UGAs. The loss of complete product could theoretically be
limited if the incorporation process was processive, because this would
mean that once a selenocysteine-incorporating ribosome complex had been
established at the first UGA in the gene sequence, subsequent UGAs
would all be recoded as selenocysteine.
However, our results are not consistent with the operation of a
processive mechanism of selenocysteine incorporation. Even if the
efficiencies seen here are not the maximum attainable, this can only
have exacerbated (but not generated) the observed result that the
combination of two or more UGAs gives rise to additional suppression of
the number of polypeptide chains that completes the open reading frame
via (multiple) selenocysteine incorporation events. This phenomenon is
therefore not attributable to a nonphysiological effect associated with
partial saturation of the selenocysteine incorporation machinery and
will apply to systems in which the absolute incorporation efficiency
per site is greater than that estimated here. Processivity apparently
does not provide the key to ensuring that multiple selenocysteine
incorporation events occur successfully. The model that emerges from
this envisages that termination can occur at any of the internal UGAs
and that the interaction of the selenocysteine incorporation machinery with the translating ribosome at one UGA does not lead to enforced incorporation at other UGAs (Fig. 6).
This may mean that there can be both assembly and disassembly of the
selenocysteine incorporation apparatus on/from the ribosome each time a
UGA is recoded. The major distinction to a processive mechanism is that
the interaction of the selenocysteine incorporation components with the
ribosome does not preprogram its subsequent behavior in a way that
commits it to multiple selenocysteine incorporation events.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Oligodeoxyribonucleotides used in this work
The plasmid constructs
2
and
1 (DR), mutations in the downstream stem-loop structure (SL), and
the presence (+) or absence (
) of the SECIS element.
1 and
2 relative to
the TGA codon, the oligonucleotide pair (PHGPXL-A and PHGPXL-B) was
digested with SalI and then subcloned between the BamHI and SalI sites of the plasmid pBPHGPx3U,
generating pT5. An oligonucleotide pair (PHGP-1-2 A/B) harboring a
region of the PHGPx gene (the amino acids serine and glutamine at
positions 44 and 45 were changed to aspartic acid and arginine,
respectively) was subcloned in the SalI site of the plasmid
pT5. To destabilize the predicted stem-loop located downstream of the
TGA codon, an oligonucleotide pair (PHGP-LOA and PHGP-LOB) containing
mutations in the stem-loop was subcloned into the SalI site
of the plasmid pT5.
-Galactosidase and luciferase activities were measured according to
the protocol described previously (24). Selenium supplementation, where
used, was achieved by adding
Na2Se2O3 to give a final
concentration of 5 µg l
1.
-galactosidase and luciferase, which are fused
in-frame via a selenoprotein gene sequence including TGA stop codon(s) (24). Upon transfection of the respective plasmids into BHK-21 cell
lines, the DNA is transcribed under control of the SV40 promoter, and
translation leads to the synthesis of reporter enzymes. Translation terminates at the internal in-frame UGA stop codon, which leads to the
synthesis of
-galactosidase enzyme. The presence of a SECIS element
in the 3'-UTR suppresses the UGA stop codon by directing recoding for
selenocysteine, which leads to the production of the
-galactosidase-luciferase fusion protein. Calculation of either
termination or suppression efficiency is based on the parallel transfection of a plasmid which contains TGC (cysteine) instead of TGA.
The ratio of enzymatic activities of the cells transfected with this
plasmid was taken as the reference value (set at 100%). In the
investigation of the influence of the +4 position on selenocysteine incorporation, the value obtained with G was taken as the 100% reference value.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-galactosidase and luciferase (Fig. 1). Because we found
that supplementation of the culture medium with
Na2SeO3 had no effect on the results obtained
with this reporter system (data not shown), all the experiments
described in this paper were performed in the absence of a selenium
supplement.

View larger version (12K):
[in a new window]
Fig. 1.
The reporter system used in this work.
This was based on the master construct described previously (24). The
lacZ and Luc reading frames are joined by a
spacer region that in the current work comprises segments of naturally
occurring selenoprotein genes, as indicated in the later figures in
this paper. In the absence of a SECIS element, termination at a UGA
within the spacer yields a C-terminally extended version of
-galactosidase. Suppression of the UGA mediated by a SECIS element
leads to synthesis of a
-gal::Luc fusion protein with both
enzyme activities.

View larger version (19K):
[in a new window]
Fig. 2.
The influence of position +4 relative to the
UGA codon on selenocysteine incorporation. A, a segment
of the porcine PHGPx gene (GenBankTM accession number
X76009) containing nucleotides 165-255 was used as the site of
selenocysteine incorporation between lacZ and Luc
(compare Fig. 1). The TGA codon is overlined. The
arrows indicate nucleotides that could form a putative
stem-loop structure (see panel C). B, the above
region was inserted between the BamHI and SalI
sites of plasmids pBLUGA and pBPHGPx3' U (Ref. 24, Fig. 1, and Table
I). The fourth base was varied as shown. The TGA codon was also changed
to TGC to generate cysteine-encoding controls. The efficiency of
SECIS-dependent stop codon suppression was determined by
measuring the activities of luciferase and
-galactosidase in
transient transfection experiments of BHK-21 cells using plasmids
without and with the PHGPx SECIS element. The luciferase activity was
normalized to the activity of
-galactosidase using as a reference
the efficiency obtained with cells that contained a TGC control
construct. Each SECIS-dependent relative efficiency was
then corrected by subtracting the corresponding SECIS-independent stop
codon suppression efficiency. The values given here are expressed as
percentages of the value obtained with the plasmid containing a guanine
nucleotide in the +4 base position. The relative efficiencies represent
mean values (± standard deviations), each of which was obtained from
at least six different transfection experiments. All transfection
experiments were carried out in duplicate. C, the effect of
predicted downstream secondary structure on selenocysteine
incorporation. To destabilize the putative downstream stem-loop, the
nucleotides G, A, and C were changed to A, U, and U, respectively. The
relative values obtained for the wild type (WL) and modified
(SL) versions of the putative stem-loop structures are
indicated.

View larger version (31K):
[in a new window]
Fig. 3.
A, the amino acids at positions
2 and
1 were changed to aspartic acid and arginine, respectively. The
effect of mutations (DR) in the penultimate and final codons
on selenocysteine incorporation in transient transfection experiments
is evident in the comparative Luc/
-gal values shown next to the
diagram (wild type set to 100%). B, analysis of the amino
acid context of selenoprotein genes. The amino acids aspartic acid and
arginine, which promote efficient termination, are not encoded at the
2 and
1 positions of any known selenoprotein genes.
U43285, mouse selenophosphate synthetase 2;
L417321, Rana catesbeiana 5' deiodinase type III;
U11762, Canis familiaris type I iodothyronine
deiodinase; AF093774, human type 2 iodothyronine deiodinase;
U67890, mouse selenoprotein W; X13709, human
glutathione peroxidase; X76009, pig phospholipid
hydroperoxide glutathione peroxidase; X99807, mouse
selenoprotein P.

View larger version (26K):
[in a new window]
Fig. 4.
Co-transfection of selC and
selD genes. Transient co-transfections of BHK-21
cells were performed using the relevant plasmids (pH8B, pH8A, pH9A,
pT12, and pT15) along with plasmids bearing selC and
selD genes. Stop codon suppression efficiencies were
estimated relative to the values obtained in control (Cont.)
cells lacking co-transfected plasmids. Reporter constructs were used
containing either UGAC (A) or UGAG (B) as
selenocysteine incorporation site. Co-transfection experiments were
performed using expression constructs encoding eRF1, eRF3, or both eRF1
and eRF3 (C). The lacZ::luc reporter
constructs used had either no SECIS element in the 3'-UTR (pBPLUGA),
only the PHGPx SECIS element (pBPPHGPx), the entire PHGPx 3'-UTR
(pBPHGPx3U), or the rat 5'-deiodinase SECIS (pBDI).

View larger version (30K):
[in a new window]
Fig. 5.
Effect of multiple UGAs on selenocysteine
incorporation. A, a segment of the selP gene
(GenBankTM accession number Z11793; nucleotides 934-990),
containing two UGA codons, was inserted into the BamHI site
of the reporter construct (Fig. 2B). This diagram indicates the
relative positions of the PHGPx UGA codon and the two selP
UGA codons. The synthetic copy of the selenoprotein P gene segment
inserted was as follows: 5'-GA TCT TGA TGC TGC CAT TGT CGA
CAT CTG ATA TTT GAA AAA ACA GGG TCT GCA ATC ACC TGA TTA
G-3'. The selenocysteine incorporation sites are underlined
or boxed. B, selenocysteine incorporation at
multiple sites. Reporter plasmids pT18-pT32 (Table II) were used for
transfection of BHK-21 cells, and SECIS-dependent stop
codon suppression efficiencies were determined. TGA or TGC codons are
indicated by 1 or 0 on the x axis. C, Western
blotting indicates the relative amounts of
-gal::Luc
fusion protein synthesized under the direction of constructs bearing
one or two UGA codons. Extracts were prepared from transiently
transfected BHK-21 cells, separated on a 6% SDS/polyarylamide gel, and
proteins were blotted onto a polyvinylidene difluoride membrane. The
-gal-Luc fusion protein (approximately 178 kDa) was detected using
anti-luciferase antibody. The control cells were not transfected. The
presence of TGA or TGC at each position is indicated by a 1 or a 0, respectively. The SECIS-mediated incorporation accounts for a large
proportion of the fusion protein synthesized in the presence of one or
two UGAs.
-
galactosidase::luciferase protein detectable in cell extracts
by means of Western blotting (Fig. 5C). The sharp reduction
in the abundance of the full-length protein upon the introduction of
more than one UGA into the reporter system is clearly apparent. Two
further types of result indicate that this is due to alterations in the
overall efficiency of selenocysteine incorporation rather than changes
in the fate of the mRNA. First, we found that the levels of
-galactosidase encoded by these constructs were not reduced in
response to the introduction of additional UGA codons (data not shown).
Had there been general destabilization of the fusion mRNAs, we
would have expected an associated loss of measurable
-galactosidase activity. Second, quantitative reverse transcriptase-PCR experiments also indicated that these changes were
not attributable to variations in the abundance of the mRNAs encoded by the respective constructs (data not shown). Differences in
the abundance of the encoded mRNAs were estimated to be no greater
than 2-fold with respect to the non-UGA-carrying control.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (11K):
[in a new window]
Fig. 6.
A nonprocessive model of selenocysteine
incorporation. Incorporation of selenocysteine at the first UGA in
a multiple UGA mRNA is mediated by a SECIS-binding complex that
associates with both the SECIS element and the elongating ribosome,
whereby it is capable of suppressing UGA-dependent
termination. Selenocysteine is only added substoichiometrically
(efficiency, <100%) to the elongating polypeptide chain. For those
chains where selenocysteine incorporation has been successful,
elongation continues until the second UGA. The SECIS-bound complex may
dissociate from the ribosome during this interim phase but then
reassociate once the second UGA enters the ribosomal A site. The
efficiency of incorporation at the second site is again <100%. This
model predicts that the yield obtained with multiple UGAs will be a
multiplicative function of the incorporation rates at the individual
UGA sites. However, the operation of a mechanism that is partially
processive under at least some conditions cannot be ruled out.
We have previously discussed the possibility that processivity might provide a mechanistic explanation for the generation of a selenoprotein such as SelP in adequate amounts (24). However, the current results indicate that the efficiency of selenocysteine incorporation at individual UGA sites is normally high enough to allow an adequate yield of complete SelP protein molecules in the absence of full processivity. At the same time, the proportion of prematurely terminated polypeptide chains generated from an mRNA bearing multiple UGA codons must be high. Given that genes such as SelP are likely to be rare, the resulting energetic wastage is presumably of little consequence in terms of the overall energetics of the cell.
Finally, suboptimal efficiencies of selenocysteine incorporation are
not exclusive to eukaryotic systems, because the maximum efficiency of
UGA decoding by SelB-GTP-Sec-tRNASec achieved in E. coli so far is estimated to be 7% (41). It is tempting to
rationalize such efficiencies purely in terms of the relative absolute
abundance of the respective cellular components of the selenocysteine
incorporation machineries in the two types of cell. However, as with
other cellular systems, it is unlikely that a full understanding of
rate control in the selenocysteine incorporation machinery can be
achieved until more is known about the supramolecular organization of
protein synthesis (41-43).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Marla Berry (Harvard, Boston, MA), Dr. Michel Philippe (CNRS, Rennes, France), and Dr. Alain Krol (Strasbourg, France) for providing expression constructs.
| |
FOOTNOTES |
|---|
* This work was supported by the British Biotechnology and Biological Sciences Research Council and the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ These authors contributed equally to this work.
To whom correspondence should be addressed:
Posttranscriptional Control Group, Department of Biomolecular Sciences,
UMIST, P.O. Box 88, Manchester M60 IQD, UK. E-mail:
J.McCarthy@umist.ac.uk.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: UTR, untranslated region; SECIS, selenocysteine insertion sequence; PCR, polymerase chain reaction.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Böck, A., Forchhammer, K., Heider, J., Leinfelder, W., Sawers, G., Veprek, B., and Zinoni, F. (1991) Mol. Microbiology 5, 515-520[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Böck, A., Forchhammer, K., Heider, J., and Baron, C. (1991) Trends Biochem. Sci. 16, 463-467[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Low, C. C., and Berry, M. J. (1996) Trends Bichem. Sci. 21, 203-208[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Stadtman, T. C. (1996) Annu. Rev. Biochem. 65, 83-100[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Heider, J., Baron, C., and Böck, A. (1992) EMBO J. 11, 3759-3766[Medline] [Order article via Infotrieve] |
| 6. | Berry, M. J., Banu, L., Chen, Y., Mandel, S. J., Kieffer, J. D., Harney, J. W., and Larsen, P. R. (1991) Nature 353, 273-276[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Berry, M. J., Banu, L., Harney, J. W., and Larsen, PR. (1993) EMBO J. 12, 3315-3322[Medline] [Order article via Infotrieve] |
| 8. |
Buettner, C.,
Harney, J. W.,
and Larsen, P. R.
(1998)
J. Biol. Chem.
273,
33374-33378 |
| 9. | Walczak, R., Westhof, E., Carbon, P., and Krol, A. (1996) RNA 2, 367-379[Abstract] |
| 10. | Walczak, R., Carbon, P., and Krol, A. (1998) RNA 4, 74-84[Abstract] |
| 11. |
Zinoni, F.,
Heider, J.,
and Böck, A.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
4660-4664 |
| 12. |
Baron, C.,
Heider, J.,
and Böck, A.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
4181-4185 |
| 13. |
Forchhammer, K.,
and Böck, A.
(1991)
J. Biol. Chem.
266,
6324-6328 |
| 14. |
Leinfelder, W.,
Stadtman, T. C.,
and Böck, A.
(1989)
J. Biol. Chem.
264,
9720-9723 |
| 15. | Ehrenreich, A., Forchhammer, K., Tormay, P., Veprek, B., and Böck, A. (1992) Eur. J. Biochem. 206, 767-773[Medline] [Order article via Infotrieve] |
| 16. |
Shen, Q.,
McQuilkin, P. A.,
and Newberger, P. E.
(1995)
J. Biol. Chem.
270,
30448-30452 |
| 17. |
Shen, Q.,
Wu, R.,
Leonard, J. L.,
and Newberger, P. E.
(1998)
J. Biol. Chem.
273,
5443-5446 |
| 18. |
Hubert, N.,
Walczak, R.,
Carbon, P.,
and Krol, A.
(1996)
Nucleic Acids Res.
24,
464-469 |
| 19. | Lesoon, A., Mehta, A., Singh, R., Chisolm, G., and Driscoll, D. M. (1997) Mol. Cell. Biol. 17, 1977-1985[Abstract] |
| 20. |
Copeland, P. R.,
and Driscoll, D. M.
(1999)
J. Biol. Chem.
274,
25447-25454 |
| 21. | Yamada, K., Mizutani, T., Ejiri, S., and Totsuka, T. (1994) FEBS Lett. 347, 137-142[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Berry, M. J., Maia, A. L., Kieffer, J. D., Harney, J. W., and Larsen, P. R. (1992) Endocrinology 131, 1848-1852[Abstract] |
| 23. |
Berry, M. J.,
Harney, J. W.,
Ohama, T.,
and Hatfield, D. L.
(1994)
Nucleic Acids Res.
22,
3753-3759 |
| 24. |
Kollmus, H.,
Flohé, L.,
and McCarthy, J. E. G.
(1996)
Nucleic Acids Res.
24,
1195-1201 |
| 25. |
Hill, K. E.,
Lloyd, R. S.,
Yang, J. G.,
Read, R.,
and Burk, R. F.
(1991)
J. Biol. Chem.
266,
10050-10053 |
| 26. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , pp. 1.21-1.105, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 27. | Carbon, P., and Krol, A. (1991) EMBO J. 10, 599-606[Medline] [Order article via Infotrieve] |
| 28. |
Low, S. C.,
Harney, J. W.,
and Berry, M. J.
(1995)
J. Biol. Chem.
270,
21659-21664 |
| 29. | Zhouravleva, G., Frolova, L., Le Goff, X., Le Guellec, R., Inge-Vechtomov, S., Kissilev, L., and Philippe, M (1995) EMBO J. 14, 4065-4072[Medline] [Order article via Infotrieve] |
| 30. |
Tassan, J. P.,
Le Guellec, K.,
Kress, M.,
Faure, M.,
Camonis, J.,
Jacquet, M.,
and Philippe, M.
(1993)
Mol. Cell. Biol.
13,
2815-2821 |
| 31. | Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve] |
| 32. |
Towbin, H.,
Staehelin, T.,
and Gordon, G.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354 |
| 33. |
Brigelius-Flohé, R.,
Aumann, K.-D.,
Blöcker, H.,
Gross, G.,
Kiess, M.,
Klöppel, K.-D.,
Maiorino, M.,
Rovri, A.,
Schuckelt, R.,
Ursini, F.,
Wingender, E.,
and Flohé, L.
(1994)
J. Biol. Chem.
269,
7342-7348 |
| 34. |
McCaughan, K. K.,
Brown, C. M.,
Dalphin, M. E.,
Berry, M. J.,
and Tate, W. P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5431-5435 |
| 35. | Bjornsson, A., Mottagui-Tabar, S., and Isaksson, L. A. (1996) EMBO J. 15, 1696-1704[Medline] [Order article via Infotrieve] |
| 36. | Moustafa, M. E., El-Saadan, M. A., Kandeel, K. M., Mansur, D. E., Lee, B. J., Hatfield, D. L., and Diamond, A. M. (1998) RNA 4, 1436-1443[Abstract] |
| 37. | Maquat, L. (1996) Am. J. Hum. Genet. 59, 279-286[Medline] [Order article via Infotrieve] |
| 38. | Bermano, G., Arthur, J. R., and Hesketh, J. E. (1996) FEBS Lett. 387, 157-160[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Moriarty, P. M.,
Reddy, C. C.,
and Maquat, L.
(1998)
Mol. Cell. Biol.
18,
2932-2939 |
| 40. | Wingler, K., Böcher, M., Flohé, L., Kollmus, H., and Brigelius-Flohé, R. (1999) Eur. J. Biochem. 259, 149-157[Medline] [Order article via Infotrieve] |
| 41. | Suppmann, S., Persson, B. C., and Böck, A. (1999) EMBO J. 18, 2284-2293[CrossRef][Medline] [Order article via Infotrieve] |
| 42. |
Negrutskii, B. S.,
Stapulionis, R.,
and Deutscher, M. P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
964-968 |
| 43. | McCarthy, J. E. G. (1998) Microbiol. Mol. Biol. Rev. 62, 1429-1553 |
This article has been cited by other articles:
![]() |
M. Rederstorff, V. Allamand, P. Guicheney, C. Gartioux, P. Richard, D. Chaigne, A. Krol, and A. Lescure Ex vivo correction of selenoprotein N deficiency in rigid spine muscular dystrophy caused by a mutation in the selenocysteine codon Nucleic Acids Res., January 17, 2008; 36(1): 237 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gupta and P. R. Copeland Functional Analysis of the Interplay between Translation Termination, Selenocysteine Codon Context, and Selenocysteine Insertion Sequence-binding Protein 2 J. Biol. Chem., December 21, 2007; 282(51): 36797 - 36807. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Nasim and R. C. Trembath A dual-light reporter system to determine the efficiency of protein-protein interactions in mammalian cells Nucleic Acids Res., April 11, 2005; 33(7): e66 - e66. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mehta, C. M. Rebsch, S. A. Kinzy, J. E. Fletcher, and P. R. Copeland Efficiency of Mammalian Selenocysteine Incorporation J. Biol. Chem., September 3, 2004; 279(36): 37852 - 37859. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Rengby, L. Johansson, L. A. Carlson, E. Serini, A. Vlamis-Gardikas, P. Karsnas, and E. S. J. Arner Assessment of Production Conditions for Efficient Use of Escherichia coli in High-Yield Heterologous Recombinant Selenoprotein Synthesis Appl. Envir. Microbiol., September 1, 2004; 70(9): 5159 - 5167. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. JAMESON and A. M. DIAMOND A regulatory role for Sec tRNA[Ser]Sec in selenoprotein synthesis RNA, July 1, 2004; 10(7): 1142 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
Md. T. Nasim, H. M. Chowdhury, and I. C. Eperon A double reporter assay for detecting changes in the ratio of spliced and unspliced mRNA in mammalian cells Nucleic Acids Res., October 15, 2002; 30(20): e109 - e109. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Hatfield and V. N. Gladyshev How Selenium Has Altered Our Understanding of the Genetic Code Mol. Cell. Biol., June 1, 2002; 22(11): 3565 - 3576. [Full Text] [PDF] |
||||
![]() |
S. Ma, K. E. Hill, R. M. Caprioli, and R. F. Burk Mass Spectrometric Characterization of Full-length Rat Selenoprotein P and Three Isoforms Shortened at the C Terminus. EVIDENCE THAT THREE UGA CODONS IN THE mRNA OPEN READING FRAME HAVE ALTERNATIVE FUNCTIONS OF SPECIFYING SELENOCYSTEINE INSERTION OR TRANSLATION TERMINATION J. Biol. Chem., April 5, 2002; 277(15): 12749 - 12754. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||